FIELD: medicine.
SUBSTANCE: present invention relates to ophthalmology and is a gel-like artificial tear with antiseptic and reparative effects, including the sodium salt of hyaluronic acid, dexpanthenol, boric acid, sodium dihydrogen phosphate dihydrate, sodium hydrophosphate dodecahydrate, sodium chloride, potassium chloride and water, while these components in the composition of artificial tears are in a certain ratio, in mg/ml.
EFFECT: improving the moisturizing properties of eye drops, improving the protective properties due to prosthetics of the tear film composition with a more effective complex composition that is well tolerated and provides a more stable and long-lasting moisturizing, lubrication and protection of the ocular surface in dry eye syndrome and other disorders of the tear film.
1 cl, 2 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
| EYE GEL DROPS FOR TREATMENT OF INFLAMMATORY, VIRUS, BACTERIAL, ALLERGIC, METABOLIC, TRAUMATIC DISEASES | 2017 |
|
RU2688687C1 |
| GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
| THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
| EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
| GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
| EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
